The disruptive effects of methamphetamine on delayed-matching-to-sample performance reflect proactive interference and are reduced by SCH23390

Pharmacol Biochem Behav. 2015 Jan:128:62-7. doi: 10.1016/j.pbb.2014.11.009. Epub 2014 Nov 13.

Abstract

Different drugs produce different patterns of impairment on delayed matching-to-sample tasks. For example, (+/-)3,4-methylenedioxymethamphetamine (MDMA) produces an increase in proactive interference. That is, subjects are less accurate when they are required to make a response different to the one they made on the immediately previous trial. The current study assessed whether methamphetamine also produces this particular pattern of disruption in delayed matching-to-sample performance in rats. Methamphetamine primarily reduced accuracy on trials where the correct response differed from the one made on the previous trial. Thus methamphetamine, like MDMA and other stimulant-based drugs of abuse, increased proactive interference. This impairment was reduced by prior administration of the dopamine D1 antagonist SCH23390. These results further extend a general conclusion that a range of stimulant-based drugs may disrupt working memory function indirectly via a tendency to repeat previously made responses and that this disruption is related to D1 receptor activity.

Keywords: Delayed matching-to-sample; Memory; Methamphetamine; Proactive interference; Rats.

MeSH terms

  • Amphetamine-Related Disorders / physiopathology
  • Amphetamine-Related Disorders / psychology
  • Animals
  • Benzazepines / administration & dosage
  • Benzazepines / pharmacology*
  • Central Nervous System Stimulants / administration & dosage
  • Central Nervous System Stimulants / antagonists & inhibitors
  • Central Nervous System Stimulants / toxicity
  • Disease Models, Animal
  • Dopamine Antagonists / administration & dosage
  • Dopamine Antagonists / pharmacology
  • Male
  • Memory Disorders / chemically induced
  • Memory Disorders / physiopathology
  • Memory Disorders / psychology
  • Memory, Short-Term / drug effects*
  • Memory, Short-Term / physiology
  • Methamphetamine / administration & dosage
  • Methamphetamine / antagonists & inhibitors
  • Methamphetamine / toxicity*
  • N-Methyl-3,4-methylenedioxyamphetamine / toxicity
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Dopamine D1 / physiology

Substances

  • Benzazepines
  • Central Nervous System Stimulants
  • Dopamine Antagonists
  • Receptors, Dopamine D1
  • SCH 23390
  • Methamphetamine
  • N-Methyl-3,4-methylenedioxyamphetamine